Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging
Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging
复制标题
DOI:
10.1016/j.nano.2012.11.009
复制
发表时间:
2013-07-01
影响因子:
5.4
通讯作者:
Batt, Carl A.
中科院分区:
文献类型:
--
作者:
Kirui, Dickson K.;Khalidov, Ildar;Batt, Carl A.
We report the use of immuno-targeted gold-iron oxide hybrid nanoparticles for laser-assisted therapy and for MRI-based imaging as demonstrated in xenograft colorectal cancer tumor model. Immuno-targeted gold-iron oxide nanoparticles selectively accumulate in SW1222 xenograft tumors as compared to the accumulation in non-antigen-expressing tumor xenografts. Effective photothermal treatment using near-IR laser irradiation (808 nm, 5 W cm(-2)) application is shown where >65% of the antigen-expressing tumor cells presented corrupt extracellular matrix and cytoplasmic acidophilia suggesting effectiveness of nanoparticle-assisted thermal therapy. Cell killing was confirmed by hematoxylin and eosin (H&E) histological staining where scar-like structure containing collagen bundles was observed in the treatment group. Further, systemically injected HNPs were shown to be effective T-2 magnetic resonance (MR) imaging contrast agents, localized and detected at the antigen-expressing xenograft tumors. These findings suggest that the new class of bio-conjugated HNPs exhibits great potential for dual-therapy and diagnostics (theranostics) applications. From the Clinical Editor: This team reports the successful use of immuno-targeted gold-iron oxide hybrid nanoparticles for both laser-assisted therapy and MRI-based imaging in a xenograft colorectal cancer tumor model, demonstrating strong potentials for dual applications in cancer diagnosis and therapy. (C) 2013 Elsevier Inc. All rights reserved.